Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Privitera

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Autoimmunity Reviews|April 18, 2021
Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapyGiuseppe Privitera, Daniela Pugliese, Sara Onali, et al.
Annali Italiani Di Chirurgia|May 19, 2010
[Benign phylloides tumor of the breast. Considerations on a clinical case]Antonio Biondi, Michela Di Giuntao, Salvatore Motta, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 3, 2008
Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell lineAleksandra M Ristić-Fira, Ivan M Petrović, Lela B Korićanac, et al.
Journal of Clinical Medicine|February 10, 2024
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative ColitisGiuseppe Cuccia, Giuseppe Privitera, Federica Di Vincenzo, et al.
Therapeutic Advances in Gastroenterology|May 17, 2021
Novel trends with biologics in inflammatory bowel disease: sequential and combined approachesGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Micromachines|August 28, 2025
Pre-Silicon Accurate SPICE Modeling of Trench MOSFETs via Advanced TCAD Simulations and Dynamic ValidationAmmar Tariq, Giovanni Minardi, Valeria Cinnera Martino, et al.
Tumori|February 12, 2004
Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project)Corrado Spatola, Giuseppe Privitera, Luigi Raffaele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2021
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel DiseaseDaniela Pugliese, Giuseppe Privitera, Tommaso Schepis, et al.
World Journal of Gastroenterology|January 24, 2022
Orphan patients with inflammatory bowel disease - when we treat beyond evidenceGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Tumori|May 19, 2015
Very elderly (>80 years), frail patients with muscle-invasive bladder cancer and comorbidities: is curative irradiation feasible?Anna Santacaterina, Angelo Platania, Carmela Palazzolo, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Autoimmunity Reviews|April 18, 2021
Combination therapy in inflammatory bowel disease - from traditional immunosuppressors towards the new paradigm of dual targeted therapyGiuseppe Privitera, Daniela Pugliese, Sara Onali, et al.
Annali Italiani Di Chirurgia|May 19, 2010
[Benign phylloides tumor of the breast. Considerations on a clinical case]Antonio Biondi, Michela Di Giuntao, Salvatore Motta, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 3, 2008
Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell lineAleksandra M Ristić-Fira, Ivan M Petrović, Lela B Korićanac, et al.
Journal of Clinical Medicine|February 10, 2024
Predictors of Efficacy of Janus Kinase Inhibitors in Patients Affected by Ulcerative ColitisGiuseppe Cuccia, Giuseppe Privitera, Federica Di Vincenzo, et al.
Therapeutic Advances in Gastroenterology|May 17, 2021
Novel trends with biologics in inflammatory bowel disease: sequential and combined approachesGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Micromachines|August 28, 2025
Pre-Silicon Accurate SPICE Modeling of Trench MOSFETs via Advanced TCAD Simulations and Dynamic ValidationAmmar Tariq, Giovanni Minardi, Valeria Cinnera Martino, et al.
Tumori|February 12, 2004
Clinical application of proton beams in the treatment of uveal melanoma: the first therapies carried out in Italy and preliminary results (CATANA Project)Corrado Spatola, Giuseppe Privitera, Luigi Raffaele, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 3, 2021
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel DiseaseDaniela Pugliese, Giuseppe Privitera, Tommaso Schepis, et al.
World Journal of Gastroenterology|January 24, 2022
Orphan patients with inflammatory bowel disease - when we treat beyond evidenceGiuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso, et al.
Tumori|May 19, 2015
Very elderly (>80 years), frail patients with muscle-invasive bladder cancer and comorbidities: is curative irradiation feasible?Anna Santacaterina, Angelo Platania, Carmela Palazzolo, et al.
Pageof 10